Fahao Zhang - Concepedia

Author

Fahao Zhang

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Fahao Zhang

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center NYU Langone Health Foundation Medicine (United States)Guardant (United States)University of Cincinnati Medical Center

About

Fahao Zhang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Cell Biology	13	13	1.1K
3	Health Sciences	2	2	71
4	Natural Sciences	1	1	48
5	Biochemistry	1	1	48

Fahao Zhang

Publications

Citations

H-Index

Page 1

	Year	Citations
Structure-based classification predicts drug response in EGFR-mutant NSCLC Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan, Nature	2021	416
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity Jacqulyne Robichaux, Yasir Y. Elamin, R.S.K. Vijayan, Cancer Cell Pan-cancer LandscapeOncologyMedicineClinically Active InhibitorCancer Genomics	2019	226
Circulating Monocytes Expressing CD31 Sun‐Jin Kim, Jang‐Seong Kim, John Papadopoulos, American Journal Of Pathology InflammationGranulocyteHematologyImmunologyBlood Cell	2009	156
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma Yu Qian, Ana Galan Cobo, Irene Guijarro, Cancer Cell MedicineImmunologyTumor ImmunityTumor SuppressorMct4-dependent Lactate Secretion	2023	153
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells Zhongping Gu, Shen Gao, Fahao Zhang, Biochemical Journal Prmt5 ExpressionTumor MicroenvironmentCell SignalingMedicineCancer Growth	2012	140
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Sonia Patel, Monique B. Nilsson, Yan Yang, Clinical Cancer Research	2023	124
<i>STK11</i> /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition Piyada Sitthideatphaiboon, Ana Galan Cobo, Marcelo V. Negrão, Clinical Cancer Research	2020	108
Transforming Growth Factor-β2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain Chen‐Yu Zhang, Fahao Zhang, Rachel Tsan, Cancer Research	2009	88
Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype Monique B. Nilsson, Jacqulyne Robichaux, Matthew H. Herynk, Journal of Thoracic Oncology Endothelial Cell PathobiologyAngiogenesisAltered RegulationDrug-resistant Egfr-mutant NsclcVascular Pharmacology	2020	69
Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude mice Guangwen Cao, Jingdong Su, Weixin Lu, Cancer Gene Therapy Gene TherapiesNude MiceMedicineImmunologyCancer Cell Biology	2001	65

Page 1